[1] Karnad DR, Bhadade R, Verma PK, et al. Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study[J]. Intensive Care Med,2014, 40: 830.
[2] Abraham P, Rodriques J, Moulick N, et al.Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis[J]. J Assoc Physicians India, 2013,61:535.
[3] Leng YX,Yang SG, Song YH, et al. ulinastatin for acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis[J]. World J Crit Care Med, 2014,3(1): 34.
[4] Huang Y, Xie K, Zhang J, et al. Prospective clinical and experimental studies on the cardioprotective effect of ulinastatin following[J]. Severe Burn, Burn, 2008,34:674.
[5] 陈文兰.乌司他丁在创伤性失血性休克治疗与疾病转归中的疗效评价[J].中国基层医药,2012(12):2.
[6] 陈怿,罗家劲,江东新,等.乌司他丁对重症中暑急性肺损伤的作用及机制研究[J].解放军医学杂志,2017, 42(4): 6.
[7] 冯筑生,范颖楠,尹文.乌司他丁治疗急性百草枯中毒的系统评价与meta分析[J].临床误诊误治,2016,29(6): 5.
[8] 林洪远,管向东.乌司他丁、α1胸腺肽联合治疗严重脓毒症——一种新的免疫调理治疗方法的临床研究[J].中华医学杂志,2007,87(7):451.
[9] 倪红英,方强,章云涛,等.乌司他丁对重症脓毒症患者炎性反应的影响及疗效评价[J].中国急救医学,2008,28(4):342.
[10] Meng C, Qian Y, Zhang WH, et al. A retrospective study of ulinastatin for the treatment of severe sepsis[J]. Medicine, 2020, 99(49):e23361.
[11] 李银平. 关于乌司他丁临床使用问题的研讨——重症医学专家座谈纪要[J]. 中华危重病急救医学, 2011, 23(11):703.
[12] 刘阳,王茜,赵慧颖,等. 乌司他丁在中国健康成年受试者中的耐受性研究[J]. 中国临床药理学杂志, 2015,31(21):2111.
[13] Chen Q, Hu CY, Liu Y,et al. Safety and tolerability of high-dose ulinastatinafter 2-hour intravenous infusion in adulthealthy Chinese volunteers: A randomized,double-blind, placebo-controlled, ascending-dose study[J]. PLoS One, 2017,12(5): e0177425.
[14] 中国医疗保健国际交流促进会,急诊医学分会中华医学会,急诊医学分会中国医师协会,急诊医师分会,中国人民解放军急救医学专业委员会.中国脓毒症早期预防与阻断急诊专家共识[J].中华急诊医学杂志,2020,29(7): 11.
[15] Zhu JB,Liu Q,Wang X,et al.A retrospective study of the effectiveness of ulinastatin in the treatment ofsepsis[J]. Emerg Crit Care Med, 2019:21037.
[16] 上海市2019冠状病毒病临床救治专家组. 上海市2019冠状病毒病综合救治专家共识[J]. 中华传染病杂志, 2020, 38(3):134.
[17] 中国医师协会胰腺病学专业委员会.中国急性胰腺炎多学科诊治(MDT)共识意见(草案)[J].中国实用内科杂志, 2015,35(12): 7.
[18] Mao E. Intensive management of severe acute pancreatitis[J]. Ann Transl Med, 2019, 7: 687.
[19] Hou J, Zhu MW, He XW et al. Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin, soluble CD14, endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis[J]. Can J Surg, 2010, 53: 241.
[20] 全军重症医学专业委员会.热射病规范化诊断与治疗专家共识(草案)[J].解放军医学杂志,2015, 40(1): 7.
[21] Lu J, Chen YP, Wan R, et al. Protective effects of ulinastatin on acute liver failure induced by lipopolysaccharide D-galactosamine[J].Dig Dis Sci,2012,57:399.
[22] Aoike, Takano, Gejyo, et al. ulinastatin gives rise to an effectual diuresis in oliguric acute renal failure[J]. Nephron,1989,52:368.
[23] Furukawa K, Kamimura T, Mahune Y, et al. Two patients with severe alcoholic hepatitis accompanied by hypercytokinemia and granulocytic hyperelastasemia, successfully treated by intravenous infusion of urinastarine (Miraclid)[J].J Gastroenterol Hepatol, 2001,16(5):575.
[24] 陆雪林,徐亚,毛果伟,等.肝素联合乌司他丁治疗妊娠晚期急性胰腺炎8例[J].中国现代医药杂志,2008,10(2):87.
[25] Sugita T, Watarida S, Katsuyama K, et al. Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass[J]. Journal of Cardiovascular Surgery, 2002, 43:437. |
